{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T09:22:35Z","timestamp":1791105755551,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2001,4,1]],"date-time":"2001-04-01T00:00:00Z","timestamp":986083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2001,4]]},"DOI":"10.1006\/nbdi.2000.0372","type":"journal-article","created":{"date-parts":[[2002,9,18]],"date-time":"2002-09-18T19:46:43Z","timestamp":1032378403000},"page":"220-239","source":"Crossref","is-referenced-by-count":72,"title":["Alterations in Cortical and Basal Ganglia Levels of Opioid Receptor Binding in a Rat Model of l-DOPA-Induced Dyskinesia"],"prefix":"10.1006","volume":"8","author":[{"given":"P.A.","family":"Johansson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.E.","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Cenci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/nbdi.2000.0372_RF1","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0166-2236(89)90074-X","article-title":"The functional anatomy of basal ganglia disorders","volume":"12","author":"Albin","year":"1989","journal-title":"Trends Neurosci."},{"key":"10.1006\/nbdi.2000.0372_RF2","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1073\/pnas.94.7.3363","article-title":"Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa","volume":"94","author":"Bordet","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/nbdi.2000.0372_RF3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1476-5381.1986.tb09474.x","article-title":"Inhibitory actions of opioid compounds on calcium fluxes and neurotransmitter release from mammalian cerebral cortical slices","volume":"88","author":"Bradford","year":"1986","journal-title":"Br. J. Pharmacol."},{"key":"10.1006\/nbdi.2000.0372_RF4","series-title":"Advances in Neurology, Dystonia 3","first-page":"41","article-title":"Opioid peptide precursor expression in animal models of dystonia secondary to dopamine-replacement therapy in Parkinson's disease","author":"Brotchie","year":"1998"},{"key":"10.1006\/nbdi.2000.0372_RF5","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1046\/j.1460-9568.1998.00285.x","article-title":"l-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin and glutamic acid decarboxylase mRNA","volume":"10","author":"Cenci","year":"1998","journal-title":"Eur. J. Neurosci."},{"key":"10.1006\/nbdi.2000.0372_RF6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1126\/science.6259732","article-title":"Morphiceptin (NH4-tyr-pro-phe-pro-COHN2): A potent and specific agonist for morphine (mu) receptors","volume":"212","author":"Chang","year":"1981","journal-title":"Science"},{"key":"10.1006\/nbdi.2000.0372_RF7","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1073\/pnas.82.12.4291","article-title":"Sequence and expression of the rat prodynorphin gene","volume":"82","author":"Civelli","year":"1985","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/nbdi.2000.0372_RF8","first-page":"461","article-title":"Kappa opiate receptor multiplicity: Evidence for two U50,488-sensitive kappa 1 subtypes and a novel kappa 3 subtype","volume":"251","author":"Clark","year":"1989","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1006\/nbdi.2000.0372_RF9","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0006-8993(98)00777-X","article-title":"Opiate receptor avidity is reduced in non-motor impaired MPTP-lesioned rhesus monkeys","volume":"806","author":"Cohen","year":"1998","journal-title":"Brain Res."},{"key":"10.1006\/nbdi.2000.0372_RF10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0014-2999(85)90754-X","article-title":"The proenkephalin A fragment, peptide E: Central processing and CNS activity in vivo","volume":"111","author":"Davis","year":"1985","journal-title":"Eur. J. Pharmacol."},{"key":"10.1006\/nbdi.2000.0372_RF11","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1046\/j.1471-4159.1994.63020777.x","article-title":"Regulation of mu-opioid receptor mRNA in rat globus pallidus: Effects of enkephalin increases induced by short- and long-term haloperidol administration","volume":"63","author":"Delfs","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1006\/nbdi.2000.0372_RF12","doi-asserted-by":"crossref","first-page":"6582","DOI":"10.1073\/pnas.84.18.6582","article-title":"Visualization of multiple opiod-receptor types in rat striatum after specific mesencehalic lesions","volume":"84","author":"Eghbali","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/nbdi.2000.0372_RF13","series-title":"Handbook of Chemical Neuroanatomy","first-page":"1","article-title":"Dynorphin-containing neurons","author":"Fallon","year":"1990"},{"key":"10.1006\/nbdi.2000.0372_RF14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0306-4522(94)90061-2","article-title":"Neurotensin, substance P, delta and mu opioid receptors are decreased in basal ganglia of Parkinson's disease patients","volume":"61","author":"Fernandez","year":"1994","journal-title":"Neuroscience"},{"key":"10.1006\/nbdi.2000.0372_RF15","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1146\/annurev.ne.15.030192.001441","article-title":"The neostriatal mosaic: Multiple levels of compartmental organization in the basal ganglia","volume":"15","author":"Gerfen","year":"1992","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1006\/nbdi.2000.0372_RF16","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1523\/JNEUROSCI.11-04-01016.1991","article-title":"Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: In situ hybridization histochemical analysis","volume":"11","author":"Gerfen","year":"1991","journal-title":"J. Neurosci."},{"key":"10.1006\/nbdi.2000.0372_RF17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0006-8993(88)91217-6","article-title":"Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: An in situ hybridization histochemistry and fluorescent retrograde tracing study","volume":"460","author":"Gerfen","year":"1988","journal-title":"Brain Res."},{"key":"10.1006\/nbdi.2000.0372_RF18","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0278-5846(98)00053-0","article-title":"Opioid effects on activation of neurons in the medial prefrontal cortex","volume":"22","author":"Giacchino","year":"1998","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1006\/nbdi.2000.0372_RF19","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/cne.902940408","article-title":"Connections of the subthalamic nucleus with ventral striatopallidal parts of the basal ganglia in the rat","volume":"294","author":"Groenewegen","year":"1990","journal-title":"J. Comp. Neurol."},{"key":"10.1006\/nbdi.2000.0372_RF20","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1097\/00001756-199609020-00011","article-title":"Co-localization of mu opioid receptor is greater with dynorphin than enkephalin in rat striatum","volume":"7","author":"Guttenberg","year":"1996","journal-title":"Neuroreport"},{"key":"10.1006\/nbdi.2000.0372_RF21","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2165\/00002512-199609030-00001","article-title":"Potential of opioid antagonists in the treatment of levodopa-induced dyskinesias in Parkinson's disease","volume":"9","author":"Henry","year":"1996","journal-title":"Drugs Aging"},{"key":"10.1006\/nbdi.2000.0372_RF22","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1006\/exnr.1998.6996","article-title":"Effect of repeated l-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat","volume":"155","author":"Henry","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1006\/nbdi.2000.0372_RF23","doi-asserted-by":"crossref","first-page":"7651","DOI":"10.1073\/pnas.81.23.7651","article-title":"Molecular cloning and sequence determination of rat preproenkephaline cDNA: Sensitive probe for studying transcriptional changes in rat tissues","volume":"81","author":"Howells","year":"1984","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/nbdi.2000.0372_RF24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1146\/annurev.pa.26.040186.000423","article-title":"Opioid peptide processing and receptor selectivity","volume":"26","author":"H\u00f6llt","year":"1986","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1006\/nbdi.2000.0372_RF25","first-page":"2055","article-title":"Marked progressive loss of kappa opioid receptors in Parkinson's disease","volume":"2","author":"Izenwasser","year":"1999","journal-title":"Soc. Neurosci. Abs. 8193."},{"key":"10.1006\/nbdi.2000.0372_RF26","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/0306-4522(94)90464-2","article-title":"Delta-opioid receptor gene expression in the mouse forebrain: Localization in cholinergic neurons of the striatum","volume":"62","author":"Le Moine","year":"1994","journal-title":"Neuroscience"},{"key":"10.1006\/nbdi.2000.0372_RF27","unstructured":"Loughlin, S. E., Leslie, F. M., & Fallon, J. H.1995Endogenous opioid systems. In: The Rat Nervous System (G. Paxinos, Ed.), pp. 988\u2013996. Academic Press, San Diego."},{"key":"10.1006\/nbdi.2000.0372_RF28","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/cne.903500307","article-title":"Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: An in situ hybridization study","volume":"350","author":"Mansour","year":"1994","journal-title":"J. Comp. Neurol."},{"key":"10.1006\/nbdi.2000.0372_RF29","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1006\/mcne.1994.1015","article-title":"Kappa 1 receptor mRNA distribution in the rat CNS: Comparison to kappa receptor binding and prodynorphin mRNA","volume":"5","author":"Mansour","year":"1994","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1006\/nbdi.2000.0372_RF30","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0006-8993(94)90031-0","article-title":"mu-Opioid receptor mRNA expression in the rat CNS: Comparison to mu-receptor binding","volume":"643","author":"Mansour","year":"1994","journal-title":"Brain Res."},{"key":"10.1006\/nbdi.2000.0372_RF31","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0006-8993(86)90601-3","article-title":"Pharmacological and anatomical evidence of selective mu, delta, and kappa opioid receptor binding in rat brain","volume":"399","author":"Mansour","year":"1986","journal-title":"Brain Res."},{"key":"10.1006\/nbdi.2000.0372_RF32","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0891-0618(93)90010-2","article-title":"Delta opioid receptor mRNA distribution in the brain: Comparison to delta receptor binding and proenkephalin mRNA","volume":"6","author":"Mansour","year":"1993","journal-title":"J. Chem. Neuroanat."},{"key":"10.1006\/nbdi.2000.0372_RF33","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0166-2236(95)93946-U","article-title":"Opioid-receptor mRNA expression in the rat CNS: Anatomical and functional implications","volume":"18","author":"Mansour","year":"1995","journal-title":"Trends Neurosci."},{"key":"10.1006\/nbdi.2000.0372_RF34","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0306-4522(98)00043-8","article-title":"5-Hydroxytryptamine-induced excitatory postsynaptic currents in neocortical layer V pyramidal cells: Suppression by mu-opiate receptor activation","volume":"86","author":"Marek","year":"1998","journal-title":"Neuroscience"},{"key":"10.1006\/nbdi.2000.0372_RF35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0006-8993(86)90285-4","article-title":"Autoradiographic localization of mu- and delta-opiate receptors in the forebrain of the rat","volume":"378","author":"McLean","year":"1986","journal-title":"Brain Res."},{"key":"10.1006\/nbdi.2000.0372_RF36","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1046\/j.1471-4159.1999.0720682.x","article-title":"Differential regulation of striatal preproenkephalin and preprotachykinin mRNA levels in MPTP-lesioned monkeys chronically treated with dopamine D1 or D2 receptor agonists","volume":"72","author":"Morissette","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1006\/nbdi.2000.0372_RF37","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/ana.410250521","article-title":"Pathogenesis of dyskinesias in Parkinson's disease","volume":"25","author":"Mouradian","year":"1989","journal-title":"Ann. Neurol."},{"key":"10.1006\/nbdi.2000.0372_RF38","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0306-4522(94)00606-6","article-title":"Preproenkephalin and preprotachykinin messenger RNA expression in normal human basal ganglia and in Parkinson's disease","volume":"66","author":"Nisbet","year":"1995","journal-title":"Neuroscience"},{"key":"10.1006\/nbdi.2000.0372_RF39","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1212\/WNL.40.2.340","article-title":"Levodopa-induced dyskinesia: Review, observations and speculations","volume":"40","author":"Nutt","year":"1990","journal-title":"Neurology"},{"key":"10.1006\/nbdi.2000.0372_RF40","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0361-9230(95)02014-4","article-title":"Substantia nigra opiate receptors on basal ganglia efferents","volume":"38","author":"Ostrowski","year":"1995","journal-title":"Brain Res. Bull."},{"key":"10.1006\/nbdi.2000.0372_RF41","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0165-0173(94)00008-D","article-title":"Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry","volume":"20","author":"Parent","year":"1995","journal-title":"Brain Res. Rev."},{"key":"10.1006\/nbdi.2000.0372_RF42","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1997"},{"key":"10.1006\/nbdi.2000.0372_RF43","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/ana.410420508","article-title":"Alterations in opioid receptor binding in Parkinson's disease patients with levodopa-induced dyskinesias","volume":"42","author":"Piccini","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1006\/nbdi.2000.0372_RF44","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0960-0760(95)00072-8","article-title":"Effects of steroids on the brain opioid system","volume":"53","author":"Piva","year":"1995","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1006\/nbdi.2000.0372_RF45","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/mds.870090410","article-title":"Naltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's disease","volume":"9","author":"Rascol","year":"1994","journal-title":"Mov. Disord."},{"key":"10.1006\/nbdi.2000.0372_RF46","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/brain\/121.3.527","article-title":"Cortical motor overactivation in parkinsonian patients with l-dopa-induced peak-dose dyskinesia","volume":"121","author":"Rascol","year":"1998","journal-title":"Brain"},{"key":"10.1006\/nbdi.2000.0372_RF47","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0196-9781(90)90088-M","article-title":"Interaction of endogenous opioid peptides and other drugs with four kappa opioid binding sites in guinea pig brain","volume":"11","author":"Rothman","year":"1990","journal-title":"Peptides"},{"key":"10.1006\/nbdi.2000.0372_RF48","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1176\/ajp.143.1.118a","article-title":"Naloxone treatment of l-dopa-induced dyskinesias in Parkinson's disease [letter]","volume":"143","author":"Sandyk","year":"1986","journal-title":"Am. J. Psychiatry"},{"key":"10.1006\/nbdi.2000.0372_RF49","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1471-4159.1982.tb08693.x","article-title":"Functional activity of substantia nigra grafts reinnervating the striatum: Neurotransmitter metabolism and [14C] 2-deoxy-d-glucose autoradiography","volume":"38","author":"Schmidt","year":"1982","journal-title":"J. Neurochem."},{"key":"10.1006\/nbdi.2000.0372_RF50","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/0196-9781(82)90067-5","article-title":"Endogenous ligands for kappa-opiate receptors","volume":"3","author":"Schulz","year":"1982","journal-title":"Peptides"},{"key":"10.1006\/nbdi.2000.0372_RF51","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0006-8993(89)91605-3","article-title":"Disappearance of the mu-opiate receptor patches in the rat neostriatum following lesioning of the ipsilateral nigrostriatal dopamine pathway with 1-methyl-4-phenylpyridinium ion (MPP+): Restoration by embryonic nigral dopamine grafts","volume":"504","author":"Sirinathsinghji","year":"1989","journal-title":"Brain Res."},{"key":"10.1006\/nbdi.2000.0372_RF52","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/0306-4522(93)90309-4","article-title":"Long-term changes in striatal opioid systems after 6-hydroxydopamine lesion of rat substantia nigra","volume":"55","author":"Smith","year":"1993","journal-title":"Neuroscience"},{"key":"10.1006\/nbdi.2000.0372_RF53","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0169-328X(95)00319-N","article-title":"Regulation of kappa opioid receptor mRNA in the rat brain by \u201cbinge\u201d pattern cocaine administration and correlation with preprodynorphin mRNA","volume":"38","author":"Spangler","year":"1996","journal-title":"Mol. Brain Res."},{"key":"10.1006\/nbdi.2000.0372_RF54","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0006-8993(88)90559-8","article-title":"Decrease in delta-opioid receptor density in rat brain after chronic [d-Ala2,d-Leu5]enkephalin treatment","volume":"462","author":"Tao","year":"1988","journal-title":"Brain Res."},{"key":"10.1006\/nbdi.2000.0372_RF55","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/0006-8993(90)91231-5","article-title":"Decrease in mu-opioid receptor binding capacity in rat brain after chronic PL017 treatment","volume":"526","author":"Tao","year":"1990","journal-title":"Brain Res."},{"key":"10.1006\/nbdi.2000.0372_RF56","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0306-4522(90)90270-E","article-title":"Striatal opiate mu-receptors are not located on dopamine nerve endings in the rat","volume":"39","author":"Trovero","year":"1990","journal-title":"Neuroscience"},{"key":"10.1006\/nbdi.2000.0372_RF57","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/0006-8993(92)90912-S","article-title":"Chronic cocaine alters brain mu opiod receptors","volume":"584","author":"Unterwald","year":"1992","journal-title":"Brain Res."},{"key":"10.1006\/nbdi.2000.0372_RF58","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0006-8993(91)91186-5","article-title":"Neuroanatomical localization of kappa 1 and kappa 2 opioid receptors in rat and guinea pig brain","volume":"562","author":"Unterwald","year":"1991","journal-title":"Brain Res."},{"key":"10.1006\/nbdi.2000.0372_RF59","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1006\/exnr.1995.1069","article-title":"Localization of Mu and delta opioid receptors to anterior cingulate afferents and projection neurons and input\/output model of Mu regulation","volume":"135","author":"Vogt","year":"1995","journal-title":"Exp. Neurol."},{"key":"10.1006\/nbdi.2000.0372_RF60","series-title":"Advances in Neurology","first-page":"53","article-title":"Pathophysiology of parkinsonian motor abnormalities","author":"Wichmann","year":"1993"},{"key":"10.1006\/nbdi.2000.0372_RF61","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0024-3205(93)90451-8","article-title":"The kappa-opioid receptor: Evidence for the different subtypes","volume":"52","author":"Wollemann","year":"1993","journal-title":"Life Sci."},{"key":"10.1006\/nbdi.2000.0372_RF62","series-title":"The Rat Nervous System","first-page":"649","article-title":"Cortex: Areal and laminar structure","author":"Zilles","year":"1995"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996100903723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996100903723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T02:56:29Z","timestamp":1576551389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996100903723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,4]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,4]]}},"alternative-id":["S0969996100903723"],"URL":"https:\/\/doi.org\/10.1006\/nbdi.2000.0372","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2001,4]]}}}